drugset
drugset / Trial / NCT03029650

Scopolamine Patch Pharmacokinetics in Healthy Adults

NCT03029650 ↗

Phase 4 Completed 26 enrolled University of Iowa University of Minnesota · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The study to be performed will utilize already FDA-approved marketed products in healthy adults for the purpose to generate data for establishing rate of drug delivery of Transderm Scop® TDDS (transdermal drug delivery system) in healthy adults and to ensure safety of individuals utilizing these types of products.

Timeline

Start
2016-11
Primary completion
2017-04
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Scopolamine Unknown 0.4 mg Other
Subject Scopolamine Unknown 1.5 mg Other

Indications

No indication recorded.